INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $19,431,000 | -26.3% | 375,399 | +3.5% | 0.07% | -1.4% |
| Q1 2022 | $26,361,000 | -76.5% | 362,750 | -61.7% | 0.07% | -72.5% |
| Q4 2021 | $111,954,000 | -20.6% | 946,834 | -9.9% | 0.26% | -24.3% |
| Q3 2021 | $140,965,000 | -2.3% | 1,050,799 | +17.9% | 0.34% | -3.2% |
| Q2 2021 | $144,245,000 | +164.7% | 890,900 | +31.2% | 0.35% | +150.4% |
| Q1 2021 | $54,504,000 | +1438.4% | 679,141 | +155.9% | 0.14% | +1058.3% |
| Q3 2019 | $3,543,000 | -23.6% | 265,382 | -6.3% | 0.01% | -20.0% |
| Q2 2019 | $4,638,000 | -24.4% | 283,286 | -21.1% | 0.02% | -25.0% |
| Q1 2019 | $6,133,000 | +79.5% | 359,028 | +43.5% | 0.02% | +66.7% |
| Q4 2018 | $3,416,000 | -27.7% | 250,203 | +51.6% | 0.01% | -7.7% |
| Q3 2018 | $4,725,000 | – | 165,079 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |